Advertisement

Picture [iito] No Tracking 650x80px
Organisation › Details

Leo Pharma (Group)

LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 92 million patients in 130 countries. In 2019, the company generated net sales of DKK 10,805 million. *

 

Period Start 1990-01-01 existent
Period End 1994-07-01 existent
Products Industry pharmaceutical
  Industry 2 dermatic
Persons Person Aabo, Gitte (Leo Pharma 201511 CEO)
  Person 2 Kronborg, Anders (Leo Pharma 201510– EVP Global Finance, IT + Legal before Kinnevik Investment AB)
     
Region Region Ballerup
  Country Denmark
  Street 55 Industriparken
  City 2750 Ballerup
  Tel +45-44-945888
    Address record changed: 2020-12-02
     
Basic data Employees G: 5,001 to 10,000 (2020-04-15)
  Currency DKK
  Annual sales 10,805,000,000 (sales, net, consolidated (2019) 2019-12-31)
     
    * Document for �About Section�: Sphingotec GmbH. (4/16/20). "Press Release: SphingoTec Expands Leadership Team and Appoints Achim Plum as Managing Director and Chief Commercial Officer". Hennigsdorf.
     
   
Record changed: 2020-04-19

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Leo Pharma (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] Made Without Love 650x80px




» top